J. Goldman & Co LP

Position in RZLT — Rezolute, Inc.

CIK 1412741 NEW YORK, NY

Position in RZLT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,786,970

-$979,064 QoQ

Shares Held

585,892

+99.1% QoQ

Ownership

0.608%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names. RZLT ranks #21 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COGT	Cogent Biosciences, Inc.	779,570	$30,005,649
2	ARDX	Ardelyx, Inc.	3,000,513	$17,973,072
3	IONS	Ionis Pharmaceuticals Inc	235,260	$17,665,673
4	URGN	UroGen Pharma Ltd.	938,870	$16,880,882
5	CAPR	Capricor Therapeutics, Inc.	541,522	$16,462,268
6	REGN	Regeneron Pharmaceuticals, Inc.	16,268	$12,569,307
7	VSTM	Verastem, Inc.	1,680,752	$8,907,985
8	PRAX	Praxis Precision Medicines, Inc.	15,664	$5,046,784

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,786,970	585,892	+99.1%	Shares	Sole	2026-05-15
2025-09-30	$2,766,034	294,259	-39.5%	Shares	Sole	2025-11-14
2025-06-30	$2,167,560	486,000	+108.9%	Shares	Sole	2025-08-14
2025-03-31	$674,618	232,627	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,139,872	232,627	+330.8%	Shares	Sole	2025-02-14
2022-12-31	$111,780	54,000	0.0%	Shares	Sole	2023-02-14
2022-09-30	$147,960	54,000	0.0%	Shares	Sole	2022-11-14
2022-06-30	$174,420	54,000	0.0%	Shares	Sole	2022-08-15
2022-03-31	$182,520	54,000	-73.3%	Shares	Sole	2022-05-16
2021-12-31	$967,950	202,500	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.